Artigos de revistas sobre o tema "Immunopeptidomics"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Veja os 50 melhores artigos de revistas para estudos sobre o assunto "Immunopeptidomics".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Veja os artigos de revistas das mais diversas áreas científicas e compile uma bibliografia correta.
Ternette, Nicola, e Anthony W. Purcell. "Immunopeptidomics Special Issue". PROTEOMICS 18, n.º 12 (junho de 2018): 1800145. http://dx.doi.org/10.1002/pmic.201800145.
Texto completo da fonteShapiro, Ilja E., Marco Tognetti, Tikira Temu, Oliver M. Bernhardt, Daniel Redfern, Yuehan Feng, Roland Bruderer e Lukas Reiter. "Abstract 5376: Quantitative profiling of HLA class I and class II antigens and neoantigens in tissue biopsy and PBMC samples using an optimized mass spectrometry-based workflow". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 5376. http://dx.doi.org/10.1158/1538-7445.am2024-5376.
Texto completo da fonteMayer, Rupert L., e Karl Mechtler. "Immunopeptidomics in the Era of Single-Cell Proteomics". Biology 12, n.º 12 (12 de dezembro de 2023): 1514. http://dx.doi.org/10.3390/biology12121514.
Texto completo da fonteConnelley, Timothy, Annalisa Nicastri, Tara Sheldrake, Christina Vrettou, Andressa Fisch, Birkir Reynisson, Soren Buus et al. "Immunopeptidomic Analysis of BoLA-I and BoLA-DR Presented Peptides from Theileria parva Infected Cells". Vaccines 10, n.º 11 (11 de novembro de 2022): 1907. http://dx.doi.org/10.3390/vaccines10111907.
Texto completo da fonteChong, Chloe, George Coukos e Michal Bassani-Sternberg. "Identification of tumor antigens with immunopeptidomics". Nature Biotechnology 40, n.º 2 (11 de outubro de 2021): 175–88. http://dx.doi.org/10.1038/s41587-021-01038-8.
Texto completo da fonteMellacheruvu, Dattatreya, Rachel Pyke, Charles Abbott, Nick Phillips, Sejal Desai, Rena McClory, John West, Richard Chen e Sean Boyle. "57 Precision neoantigen discovery using novel algorithms and expanded HLA-ligandome datasets". Journal for ImmunoTherapy of Cancer 8, Suppl 3 (novembro de 2020): A62. http://dx.doi.org/10.1136/jitc-2020-sitc2020.0057.
Texto completo da fonteFoster, Leonard, Queenie Chan, Charlie Kuan e Hong Bing Yu. "A framework for unbiased, robust and system-wide characterization of MHC-bound peptides and epitopes (APP5P.111)". Journal of Immunology 194, n.º 1_Supplement (1 de maio de 2015): 183.13. http://dx.doi.org/10.4049/jimmunol.194.supp.183.13.
Texto completo da fonteKochin, Vitaly, Takayuki Kanaseki, Sho Miyamoto, Daichi Morooka, Keigo Moniwa, Yutaro Ikeuchi, Akari Takaya, Yoshihiko Hirohashi, Toshihiko Torigoe e Noriyuki Sato. "Human cancer immunopeptidomics for efficient CTL immunotherapy". Annals of Oncology 26 (novembro de 2015): vii30. http://dx.doi.org/10.1093/annonc/mdv424.02.
Texto completo da fonteIstrail, S., L. Florea, B. V. Halldorsson, O. Kohlbacher, R. S. Schwartz, V. B. Yap, J. W. Yewdell e S. L. Hoffman. "Comparative immunopeptidomics of humans and their pathogens". Proceedings of the National Academy of Sciences 101, n.º 36 (23 de agosto de 2004): 13268–72. http://dx.doi.org/10.1073/pnas.0404740101.
Texto completo da fonteGarcia‐Moure, Marc, Andrew G. Gillard, Marta M. Alonso, Juan Fueyo e Candelaria Gomez‐Manzano. "Oncolytic adenoviruses and immunopeptidomics: a convenient marriage". Molecular Oncology 18, n.º 4 (abril de 2024): 781–84. http://dx.doi.org/10.1002/1878-0261.13648.
Texto completo da fonteTegeler, Christian M., Jonas S. Heitmann, Helmut R. Salih, Juliane S. Walz e Annika Nelde. "Abstract 1972: Clinical implications of HLA expression and immunopeptidome-presented tumor antigens in ovarian carcinoma". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 1972. http://dx.doi.org/10.1158/1538-7445.am2022-1972.
Texto completo da fonteZhang, Bing, e Michal Bassani-Sternberg. "Current perspectives on mass spectrometry-based immunopeptidomics: the computational angle to tumor antigen discovery". Journal for ImmunoTherapy of Cancer 11, n.º 10 (outubro de 2023): e007073. http://dx.doi.org/10.1136/jitc-2023-007073.
Texto completo da fonteDanner, Rebecca, Michael Pereckas, Joseph Rouse, Amanda Wahhab e Robert B. Lochhead. "Expanded presentation of Lyme autoantigens and identification of a novel immunogenic CD4+ T cell epitope from Borrelia burgdorferiMCP4 in murine Lyme arthritis". Journal of Immunology 210, n.º 1_Supplement (1 de maio de 2023): 221.17. http://dx.doi.org/10.4049/jimmunol.210.supp.221.17.
Texto completo da fonteBichmann, Leon, Annika Nelde, Michael Ghosh, Lukas Heumos, Christopher Mohr, Alexander Peltzer, Leon Kuchenbecker et al. "MHCquant: Automated and Reproducible Data Analysis for Immunopeptidomics". Journal of Proteome Research 18, n.º 11 (7 de outubro de 2019): 3876–84. http://dx.doi.org/10.1021/acs.jproteome.9b00313.
Texto completo da fonteChavda, Vivek P., e Elrashdy M. Redwan. "SARS-CoV-2: Immunopeptidomics and Other Immunological Studies". Vaccines 10, n.º 11 (21 de novembro de 2022): 1975. http://dx.doi.org/10.3390/vaccines10111975.
Texto completo da fonteCourcelles, Mathieu, Chantal Durette, Tariq Daouda, Jean-Philippe Laverdure, Krystel Vincent, Sébastien Lemieux, Claude Perreault e Pierre Thibault. "MAPDP: A Cloud-Based Computational Platform for Immunopeptidomics Analyses". Journal of Proteome Research 19, n.º 4 (28 de fevereiro de 2020): 1873–81. http://dx.doi.org/10.1021/acs.jproteome.9b00859.
Texto completo da fonteBouzid, Rachid, Monique T. A. de Beijer, Robbie J. Luijten, Karel Bezstarosti, Amy L. Kessler, Marco J. Bruno, Maikel P. Peppelenbosch, Jeroen A. A. Demmers e Sonja I. Buschow. "Empirical Evaluation of the Use of Computational HLA Binding as an Early Filter to the Mass Spectrometry-Based Epitope Discovery Workflow". Cancers 13, n.º 10 (12 de maio de 2021): 2307. http://dx.doi.org/10.3390/cancers13102307.
Texto completo da fonteThibault, Pierre, e Claude Perreault. "Immunopeptidomics: Reading the Immune Signal That Defines Self From Nonself". Molecular & Cellular Proteomics 21, n.º 6 (junho de 2022): 100234. http://dx.doi.org/10.1016/j.mcpro.2022.100234.
Texto completo da fontePurcell, Anthony W., Sri H. Ramarathinam e Nicola Ternette. "Mass spectrometry–based identification of MHC-bound peptides for immunopeptidomics". Nature Protocols 14, n.º 6 (15 de maio de 2019): 1687–707. http://dx.doi.org/10.1038/s41596-019-0133-y.
Texto completo da fonteDanner, Rebecca, Michael Pereckas, Joseph Rouse, Amanda Wahhab e Robert Lochhead. "Immunopeptidomics analysis of Lyme arthritis: insights into infection and autoimmunity". Journal of Immunology 206, n.º 1_Supplement (1 de maio de 2021): 93.10. http://dx.doi.org/10.4049/jimmunol.206.supp.93.10.
Texto completo da fonteShapiro, Ilja E., e Michal Bassani-Sternberg. "The impact of immunopeptidomics: From basic research to clinical implementation". Seminars in Immunology 66 (março de 2023): 101727. http://dx.doi.org/10.1016/j.smim.2023.101727.
Texto completo da fonteFaridi, Pouya, Anthony W. Purcell e Nathan Paul Croft. "In Immunopeptidomics We Need a Sniper Instead of a Shotgun". PROTEOMICS 18, n.º 12 (7 de março de 2018): 1700464. http://dx.doi.org/10.1002/pmic.201700464.
Texto completo da fonteLi, Kai, Antrix Jain, Anna Malovannaya, Bo Wen e Bing Zhang. "DeepRescore: Leveraging Deep Learning to Improve Peptide Identification in Immunopeptidomics". PROTEOMICS 20, n.º 21-22 (27 de setembro de 2020): 1900334. http://dx.doi.org/10.1002/pmic.201900334.
Texto completo da fonteVaughan, Kerrie, Etienne Caron, Bjoern Peters e Alessandro Sette. "The future of the immunopeptidome in health and disease: a comprehensive analysis of naturally processed ligand data". Journal of Immunology 196, n.º 1_Supplement (1 de maio de 2016): 46.4. http://dx.doi.org/10.4049/jimmunol.196.supp.46.4.
Texto completo da fontePeltonen, Karita, Sara Feola, Husen M. Umer, Jacopo Chiaro, Georgios Mermelekas, Erkko Ylösmäki, Sari Pesonen, Rui M. M. Branca, Janne Lehtiö e Vincenzo Cerullo. "Therapeutic Cancer Vaccination with Immunopeptidomics-Discovered Antigens Confers Protective Antitumor Efficacy". Cancers 13, n.º 14 (7 de julho de 2021): 3408. http://dx.doi.org/10.3390/cancers13143408.
Texto completo da fonteShabani, Nor Raihan Mohammad, Che Muhammad Khairul Hisyam Ismail, Chiuan Herng Leow, Munirah Mokhtar, Kirnpal Kaur Banga Singh e Chiuan Yee Leow. "Identification of MHC Class II Immunopeptidomes from Shigella flexneri 2a-infected Macrophages as Potential Vaccine Candidates". Indonesian Biomedical Journal 14, n.º 2 (28 de junho de 2022): 139–47. http://dx.doi.org/10.18585/inabj.v14i2.1781.
Texto completo da fonteAbd El-Baky, Nawal, Amro A. Amara e Elrashdy M. Redwan. "HLA-I and HLA-II Peptidomes of SARS-CoV-2: A Review". Vaccines 11, n.º 3 (25 de fevereiro de 2023): 548. http://dx.doi.org/10.3390/vaccines11030548.
Texto completo da fonteKallor, Ashwin Adrian, Michał Waleron, Georges Bedran, Patrícia Eugénio, Catia Pesquita, Daniel Faria, Fabio Massimo Zanzotto, Christophe Battail, Ajitha Rajan e Javier Alfaro. "Abstract 6577: CARMEN: A pan-HLA and pan-cancer proteogenomic database on antigen presentation to support cancer immunotherapy". Cancer Research 83, n.º 7_Supplement (4 de abril de 2023): 6577. http://dx.doi.org/10.1158/1538-7445.am2023-6577.
Texto completo da fonteKlein, Joshua, Daniel Sprague, Monica Lane, Meghan Hart, Olivia Petrillo, Italo Faria do Valle, Matthew Davis et al. "Abstract 904: AI platform provides an EDGE and enables state-of-the-art identification of peptide-HLAs for the development of T cell inducing vaccines". Cancer Research 84, n.º 6_Supplement (22 de março de 2024): 904. http://dx.doi.org/10.1158/1538-7445.am2024-904.
Texto completo da fonteStopfer, Lauren E., Jason E. Conage-Pough e Forest M. White. "Quantitative Consequences of Protein Carriers in Immunopeptidomics and Tyrosine Phosphorylation MS2 Analyses". Molecular & Cellular Proteomics 20 (2021): 100104. http://dx.doi.org/10.1016/j.mcpro.2021.100104.
Texto completo da fonteFritsche, Jens, Barbara Rakitsch, Franziska Hoffgaard, Michael Römer, Heiko Schuster, Daniel J. Kowalewski, Martin Priemer et al. "Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection". PROTEOMICS 18, n.º 12 (10 de abril de 2018): 1700284. http://dx.doi.org/10.1002/pmic.201700284.
Texto completo da fonteLi, Kai, Antrix Jain, Anna Malovannaya, Bo Wen e Bing Zhang. "Front Cover: DeepRescore: Leveraging Deep Learning to Improve Peptide Identification in Immunopeptidomics". PROTEOMICS 20, n.º 21-22 (novembro de 2020): 2070151. http://dx.doi.org/10.1002/pmic.202070151.
Texto completo da fontePurcell, Anthony. "Mass spectrometry and immunopeptidomics – teaching us new lessons in antigen processing and presentation". Molecular Immunology 150 (outubro de 2022): 35. http://dx.doi.org/10.1016/j.molimm.2022.05.116.
Texto completo da fonteAbelin, Jennifer. "Abstract 1439 Mass spectrometry based immunopeptidomics as a tool for understanding antigen presentation". Journal of Biological Chemistry 300, n.º 3 (março de 2024): 106634. http://dx.doi.org/10.1016/j.jbc.2024.106634.
Texto completo da fonteMohsen, Mona O., Daniel E. Speiser, Justine Michaux, HuiSong Pak, Brian J. Stevenson, Monique Vogel, Varghese Philipose Inchakalody et al. "Bedside formulation of a personalized multi-neoantigen vaccine against mammary carcinoma". Journal for ImmunoTherapy of Cancer 10, n.º 1 (janeiro de 2022): e002927. http://dx.doi.org/10.1136/jitc-2021-002927.
Texto completo da fonteWilder, Brandon Keith, Luna de Lacerda, Camila R. R. Barbosa, Maya Aleshnick, Thomas Martinson, David Morrow, Zeshou Zhao, Gaurav Gaiha e Caroline Junqueira. "Malaria antigens are presented to CD8 T cells via the non-classical HLA-E". Journal of Immunology 208, n.º 1_Supplement (1 de maio de 2022): 170.27. http://dx.doi.org/10.4049/jimmunol.208.supp.170.27.
Texto completo da fonteMaringer, Yacine, Lena Freudenmann, Annika Nelde, Jonas S. Heitmann, Helmut R. Salih, Marissa Dubbelaar, Jörg Hennenlotter et al. "Abstract 3556: Immunopeptidomics-guided tumor antigen warehouse design and first clinical application of a personalized peptide vaccine for prostate cancer". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 3556. http://dx.doi.org/10.1158/1538-7445.am2022-3556.
Texto completo da fonteSolleder, Marthe, Philippe Guillaume, Julien Racle, Justine Michaux, Hui-Song Pak, Markus Müller, George Coukos, Michal Bassani-Sternberg e David Gfeller. "Mass Spectrometry Based Immunopeptidomics Leads to Robust Predictions of Phosphorylated HLA Class I Ligands". Molecular & Cellular Proteomics 19, n.º 2 (17 de dezembro de 2019): 390–404. http://dx.doi.org/10.1074/mcp.tir119.001641.
Texto completo da fonteAndreatta, Massimo, Annalisa Nicastri, Xu Peng, Gemma Hancock, Lucy Dorrell, Nicola Ternette e Morten Nielsen. "MS-Rescue: A Computational Pipeline to Increase the Quality and Yield of Immunopeptidomics Experiments". PROTEOMICS 19, n.º 4 (18 de janeiro de 2019): 1800357. http://dx.doi.org/10.1002/pmic.201800357.
Texto completo da fonteFritsche, Jens, Barbara Rakitsch, Franziska Hoffgaard, Michael Römer, Heiko Schuster, Daniel J. Kowalewski, Martin Priemer et al. "Front Cover: Translating Immunopeptidomics to Immunotherapy-Decision-Making for Patient and Personalized Target Selection". PROTEOMICS 18, n.º 12 (junho de 2018): 1870101. http://dx.doi.org/10.1002/pmic.201870101.
Texto completo da fonteStutzmann, Charlotte, Jiaxi Peng, Zhaoguan Wu, Christopher Savoie, Isabelle Sirois, Pierre Thibault, Aaron R. Wheeler e Etienne Caron. "Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery". Cell Reports Methods 3, n.º 6 (junho de 2023): 100511. http://dx.doi.org/10.1016/j.crmeth.2023.100511.
Texto completo da fonteTetens, Ashley R., Allison M. Martin, Antje Arnold, Orlandi V. Novak, Adrian Idrizi, Rakel Tryggvadottir, Jordyn Craig-Schwartz et al. "DIPG-58. TARGETING DISORDERED DNA METHYLATION IN DIPG TO CONSTRAIN VARIABILITY AND INDUCE IMMUNE SIGNALING". Neuro-Oncology 26, Supplement_4 (18 de junho de 2024): 0. http://dx.doi.org/10.1093/neuonc/noae064.111.
Texto completo da fontePyke, Rachel Marty, Steven Dea, Hima Anbunathan, Charles W. Abbott, Neeraja Ravi, Jason Harris, Gabor Bartha et al. "Abstract 5640: Mono-allelic immunopeptidomics data from 109 MHC-I alleles reveals variability in binding preferences and improves neoantigen prediction algorithm". Cancer Research 82, n.º 12_Supplement (15 de junho de 2022): 5640. http://dx.doi.org/10.1158/1538-7445.am2022-5640.
Texto completo da fonteLi, Chen, Jerico Revote, Sri H. Ramarathinam, Shan Zou Chung, Nathan P. Croft, Katherine E. Scull, Ziyi Huang et al. "Resourcing, annotating, and analysing synthetic peptides of SARS‐CoV‐2 for immunopeptidomics and other immunological studies". PROTEOMICS 21, n.º 17-18 (14 de abril de 2021): 2100036. http://dx.doi.org/10.1002/pmic.202100036.
Texto completo da fonteGraciotti, Michele, Fabio Marino, HuiSong Pak, Petra Baumgaertner, Anne-Christine Thierry, Johanna Chiffelle, Marta A. S. Perez et al. "Deciphering the Mechanisms of Improved Immunogenicity of Hypochlorous Acid-Treated Antigens in Anti-Cancer Dendritic Cell-Based Vaccines". Vaccines 8, n.º 2 (2 de junho de 2020): 271. http://dx.doi.org/10.3390/vaccines8020271.
Texto completo da fonteStopfer, L. E., A. D. D'Souza e F. M. White. "1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs". Immuno-Oncology and Technology 11 (outubro de 2021): 100042. http://dx.doi.org/10.1016/j.iotech.2021.100042.
Texto completo da fonteStopfer, L. E., A. D. D'Souza e F. M. White. "1,2,3, MHC: a review of mass-spectrometry-based immunopeptidomics methods for relative and absolute quantification of pMHCs". Immuno-Oncology and Technology 11 (outubro de 2021): 100042. http://dx.doi.org/10.1016/j.iotech.2021.100042.
Texto completo da fonteEly, Zackery A., William A. Freed-Pastor, Zachary J. Kulstad, Jennifer G. Abelin, Eva Verzani, Kevin S. Kapner, Susan Klaeger et al. "Abstract C014: Broadening the repertoire of PDAC-specific targets for immune-based therapy through high-resolution immunopeptidomics". Cancer Research 82, n.º 22_Supplement (15 de novembro de 2022): C014. http://dx.doi.org/10.1158/1538-7445.panca22-c014.
Texto completo da fonteElAbd, Hesham, Frauke Degenhardt, Tomas Koudelka, Ann-Kristin Kamps, Andreas Tholey, Petra Bacher, Tobias L. Lenz, Andre Franke e Mareike Wendorff. "Immunopeptidomics toolkit library (IPTK): a python-based modular toolbox for analyzing immunopeptidomics data". BMC Bioinformatics 22, n.º 1 (17 de agosto de 2021). http://dx.doi.org/10.1186/s12859-021-04315-0.
Texto completo da fonteWacker, Marcel, Jens Bauer, Laura Wessling, Marissa Dubbelaar, Annika Nelde, Hans-Georg Rammensee e Juliane S. Walz. "Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics". Frontiers in Immunology 14 (21 de julho de 2023). http://dx.doi.org/10.3389/fimmu.2023.1219720.
Texto completo da fonte